<!DOCTYPE html>
<html>
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<meta http-equiv="X-UA-Compatible" content="ie=edge">
<title>Markmap</title>
<style>
* {
  margin: 0;
  padding: 0;
}
#mindmap {
  display: block;
  width: 100vw;
  height: 100vh;
}
</style>
<link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/markmap-toolbar@0.18.10/dist/style.css">
</head>
<body>
<svg id="mindmap"></svg>
<script src="https://cdn.jsdelivr.net/npm/d3@7.9.0/dist/d3.min.js"></script><script src="https://cdn.jsdelivr.net/npm/markmap-view@0.18.10/dist/browser/index.js"></script><script src="https://cdn.jsdelivr.net/npm/markmap-toolbar@0.18.10/dist/index.js"></script><script>(r => {
              setTimeout(r);
            })(function renderToolbar() {
  const {
    markmap,
    mm
  } = window;
  const {
    el
  } = markmap.Toolbar.create(mm);
  el.setAttribute('style', 'position:absolute;bottom:20px;right:20px');
  document.body.append(el);
})</script><script>((getMarkmap, getOptions, root2, jsonOptions) => {
              const markmap = getMarkmap();
              window.mm = markmap.Markmap.create(
                "svg#mindmap",
                (getOptions || markmap.deriveOptions)(jsonOptions),
                root2
              );
            })(() => window.markmap,null,{"content":"ADHD Diagnostic Studies: Categorized by Measurement Type","children":[{"content":"Clinical Rating Scales and Diagnostic Interviews","children":[{"content":"1. Bakare &amp; Jordanova (2020) - Brief screening measure development","children":[],"payload":{"tag":"li","lines":"4,5","listIndex":1}},{"content":"2. Bastiaens &amp; Galus (2018) - ASRS screener comparison DSM-IV vs DSM-5","children":[],"payload":{"tag":"li","lines":"5,6","listIndex":2}},{"content":"3. Chen et al. (2021) - Machine learning ADHD classification","children":[],"payload":{"tag":"li","lines":"6,7","listIndex":3}},{"content":"4. Chiasson et al. (2012) - ASRS in ADHD + substance abuse populations","children":[],"payload":{"tag":"li","lines":"7,8","listIndex":4}},{"content":"5. Dakwar et al. (2012) - ADHD screening in substance use disorders","children":[],"payload":{"tag":"li","lines":"8,9","listIndex":5}},{"content":"6. Dunlop et al. (2018) - ASRS in major depressive disorder","children":[],"payload":{"tag":"li","lines":"9,10","listIndex":6}},{"content":"7. Eich et al. (2012) - New rating scale based on SCL-90-R","children":[],"payload":{"tag":"li","lines":"10,11","listIndex":7}},{"content":"8. Erhardt et al. (1999) - Self-ratings reliability and validity","children":[],"payload":{"tag":"li","lines":"11,12","listIndex":8}},{"content":"9. Faraone et al. (2000) - Symptom assessment children vs adults","children":[],"payload":{"tag":"li","lines":"12,13","listIndex":9}},{"content":"10. Gift et al. (2021) - Wender Utah Rating Scale psychometrics","children":[],"payload":{"tag":"li","lines":"13,14","listIndex":10}},{"content":"11. Grogan et al (2017) - CAARS, STAI (adhd and anxiety)","children":[],"payload":{"tag":"li","lines":"14,15","listIndex":11}},{"content":"12. Harrison et al (2016) - CAARS","children":[],"payload":{"tag":"li","lines":"15,16","listIndex":12}},{"content":"13. Houston et al. (2011) - Primary care screening instrument","children":[],"payload":{"tag":"li","lines":"16,17","listIndex":13}},{"content":"14. Kessler et al. (2010) - Adult ADHD Clinical Diagnostic Scale","children":[],"payload":{"tag":"li","lines":"17,18","listIndex":14}},{"content":"15. Kingston et al (2013) - Multiple measures + CPT","children":[],"payload":{"tag":"li","lines":"18,19","listIndex":15}},{"content":"16. Kwan et al (2024) - CAARS","children":[],"payload":{"tag":"li","lines":"19,20","listIndex":16}},{"content":"17. Lancaster et al (2018) - PAI","children":[],"payload":{"tag":"li","lines":"20,21","listIndex":17}},{"content":"18. Kumar et al. (2011) - MINI, CAARS, Screening in psychiatric inpatients","children":[],"payload":{"tag":"li","lines":"21,22","listIndex":18}},{"content":"19. Lewandowski et al. (2008) - College student symptom reporting","children":[],"payload":{"tag":"li","lines":"22,23","listIndex":19}},{"content":"20. Liu et al. (2023) - Machine learning screening approach","children":[],"payload":{"tag":"li","lines":"23,24","listIndex":20}},{"content":"21. Luderer et al. (2019) - ADHD screening in alcohol dependent patients","children":[],"payload":{"tag":"li","lines":"24,25","listIndex":21}},{"content":"22. Luty et al. (2009) - Self-report validation in substance users","children":[],"payload":{"tag":"li","lines":"25,26","listIndex":22}},{"content":"23. Marchant et al. (2015) - Self-Report Wender-Reimherr Scale","children":[],"payload":{"tag":"li","lines":"26,27","listIndex":23}},{"content":"24. Mattos et al. (2018) - DSM criteria in medical students","children":[],"payload":{"tag":"li","lines":"27,28","listIndex":24}},{"content":"25. McCann &amp; Roy-Byrne (2004) - Self-report scales utility","children":[],"payload":{"tag":"li","lines":"28,29","listIndex":25}},{"content":"26. Mehringer et al. (2002) - Assessment of Hyperactivity and Attention tool","children":[],"payload":{"tag":"li","lines":"29,30","listIndex":26}},{"content":"27. Notzon et al. (2020) - CAADID, ADHD in cannabis use disorders","children":[],"payload":{"tag":"li","lines":"30,31","listIndex":27}},{"content":"28. Palma-&#xc1;lvarez et al. (2023) - MINI-Plus ADHD module validation","children":[],"payload":{"tag":"li","lines":"31,32","listIndex":28}},{"content":"29. Palmer et al. (2023) - Screening in young autistic adults","children":[],"payload":{"tag":"li","lines":"32,33","listIndex":29}},{"content":"30. Reimherr et al. (2021) - Wender Utah Rating Scale versions","children":[],"payload":{"tag":"li","lines":"33,34","listIndex":30}},{"content":"31. Reyes et al. (2019) - ASRS utility in alcoholics","children":[],"payload":{"tag":"li","lines":"34,35","listIndex":31}},{"content":"32. Singh et al. (2015) - IPDE screening questionnaire","children":[],"payload":{"tag":"li","lines":"35,36","listIndex":32}},{"content":"33. Ustun et al. (2017) - WHO Adult ADHD Self-Report Scale","children":[],"payload":{"tag":"li","lines":"36,37","listIndex":33}},{"content":"34. van de Glind et al. (2013) - ASRS in substance use disorders","children":[],"payload":{"tag":"li","lines":"37,38","listIndex":34}},{"content":"35. Van Voorhees et al. (2011) - Self and other-ratings reliability","children":[],"payload":{"tag":"li","lines":"38,39","listIndex":35}},{"content":"36. Vitola et al. (2017) - DSM-5 criteria exploration","children":[],"payload":{"tag":"li","lines":"39,40","listIndex":36}},{"content":"37. Vizgaitis et al. (2023) - Self-reported symptoms analysis","children":[],"payload":{"tag":"li","lines":"40,41","listIndex":37}},{"content":"38. Young et al. (2016) - BAARS-IV, Prison inmate screening tool","children":[],"payload":{"tag":"li","lines":"41,42","listIndex":38}},{"content":"39. Young et al. (2005) - YAQ-S and YAQ-I symptomatology","children":[],"payload":{"tag":"li","lines":"42,43","listIndex":39}},{"content":"40. Young et al. (2023) - ASSET-BS screening measure development","children":[],"payload":{"tag":"li","lines":"43,45","listIndex":40}}],"payload":{"tag":"h2","lines":"2,3"}},{"content":"Neuropsychological and Cognitive Tests","children":[{"content":"1. Adamou et al (2022) - Qb Test","children":[],"payload":{"tag":"li","lines":"47,48","listIndex":1}},{"content":"2. Brunkhorst-Kanaan (2020) - QB Test","children":[],"payload":{"tag":"li","lines":"48,49","listIndex":2}},{"content":"3. Cohen &amp; Shapiro (2007) - Flicker task and CPT comparison","children":[],"payload":{"tag":"li","lines":"49,50","listIndex":3}},{"content":"4. Edebol et al (2012) - QB Test, ADHD, Bipolar, Borderline PD","children":[],"payload":{"tag":"li","lines":"50,51","listIndex":4}},{"content":"5. Edebol et al (2013) - QB Test","children":[],"payload":{"tag":"li","lines":"51,52","listIndex":5}},{"content":"6. Elbaum et al. (2020) - MOXO-dCPT with eye tracking","children":[],"payload":{"tag":"li","lines":"52,53","listIndex":6}},{"content":"7. Emser et al. (2018) - TAP, QB Test (child and adult), CAARS, Conners-3<br>\n(child) <strong>(exclude?)</strong>","children":[],"payload":{"tag":"li","lines":"53,55","listIndex":7}},{"content":"8. Kovner et al. (1998) - Neuropsychological testing pilot study; multiple tests","children":[],"payload":{"tag":"li","lines":"55,56","listIndex":8}},{"content":"9. Lee Booksh et al. (2010) - Attention measures in college students; multiple tests","children":[],"payload":{"tag":"li","lines":"56,57","listIndex":9}},{"content":"10. Lev et al. (2022) - MOXO-dCPT with eye tracking","children":[],"payload":{"tag":"li","lines":"57,58","listIndex":10}},{"content":"11. Lovejoy et al. (1999) - Executive function measures (multiple)","children":[],"payload":{"tag":"li","lines":"58,59","listIndex":11}},{"content":"12. Mostert et al. (2015) - DIVA + multiple neuropsychological tests","children":[],"payload":{"tag":"li","lines":"59,60","listIndex":12}},{"content":"13. Nielsen &amp; Wiig (2011) - A Quick Test of Cognitive Speed (AQT)","children":[],"payload":{"tag":"li","lines":"60,61","listIndex":13}},{"content":"14. Paucke et al. (2021) - Go/NoGo + WURS + CAARS","children":[],"payload":{"tag":"li","lines":"61,62","listIndex":14}},{"content":"15. Pettersson et al. (2018) - DIVA 2.0 + ASRS vs 8 Neuropsychological tests","children":[],"payload":{"tag":"li","lines":"62,63","listIndex":15}},{"content":"16. Schreiber et al. (1999) - Rey-Osterrieth Complex Figure validation","children":[],"payload":{"tag":"li","lines":"63,64","listIndex":16}},{"content":"17. Shepler &amp; Callan (2024) - Executive functioning differences","children":[],"payload":{"tag":"li","lines":"64,65","listIndex":17}},{"content":"18. S&#xf6;derstr&#xf6;m et al. (2014) - QB Test + ASRS","children":[],"payload":{"tag":"li","lines":"65,66","listIndex":18}},{"content":"19. Solanto et al. (2004) - (WURS, CAARS, Brown ADD for dx) Conners CPT","children":[],"payload":{"tag":"li","lines":"66,67","listIndex":19}},{"content":"20. Spenceley et al. (2022) - Woodcock-Johnson IV detection","children":[],"payload":{"tag":"li","lines":"67,68","listIndex":20}},{"content":"21. Unal et al. (2019) - Stroop test, Stroop Plus, and Perceptual<br>\nSelectivity test","children":[],"payload":{"tag":"li","lines":"68,70","listIndex":21}},{"content":"22. Wiig &amp; Nielsen (2012) - A Quick Test of Cognitive Speed (AQT)","children":[],"payload":{"tag":"li","lines":"70,71","listIndex":22}},{"content":"23. Woods et al. (2002) - Multiple neuropsych tests","children":[],"payload":{"tag":"li","lines":"71,73","listIndex":23}}],"payload":{"tag":"h2","lines":"45,46"}},{"content":"Neuroimaging Studies","children":[{"content":"1. Amen et al. (2021) - SPECT functional neuroimaging","children":[],"payload":{"tag":"li","lines":"75,76","listIndex":1}},{"content":"2. Alves et al. (2024) - fMRI functional connectivity analysis, ADHD, ASD","children":[],"payload":{"tag":"li","lines":"76,77","listIndex":2}},{"content":"3. Chaim-Avancini et al. (2017) - MRI pattern recognition","children":[],"payload":{"tag":"li","lines":"77,78","listIndex":3}},{"content":"4. Schneider et al. (2014) - SPECT imaging comparison","children":[],"payload":{"tag":"li","lines":"78,79","listIndex":4}},{"content":"5. Wang et al. (2013) - Regional homogeneity patterns resting-state fMRI","children":[],"payload":{"tag":"li","lines":"79,80","listIndex":5}},{"content":"6. Wang et al. (2023) - Deep learning classification fMRI","children":[],"payload":{"tag":"li","lines":"80,81","listIndex":6}},{"content":"7. Wolfers et al. (2016) - Brain activity pattern quantification, UN<br>\nAFF, ADHD, Controls","children":[],"payload":{"tag":"li","lines":"81,83","listIndex":7}},{"content":"8. Yao et al. (2018) - Machine learning feature selection rs-fMRI","children":[],"payload":{"tag":"li","lines":"83,86","listIndex":8}}],"payload":{"tag":"h2","lines":"73,74"}},{"content":"EEG/Electrophysiological Studies","children":[{"content":"1. Biederman et al (2017) - Brain Network Activation (BNA), a novel ERP-based brain network<br>\nanalysis","children":[],"payload":{"tag":"li","lines":"88,90","listIndex":1}},{"content":"2. Hadas et al. (2021) - TMS-EEG prefrontal activation","children":[],"payload":{"tag":"li","lines":"90,91","listIndex":2}},{"content":"3. Kaur et al. (2020) - EEG phase space reconstruction","children":[],"payload":{"tag":"li","lines":"91,92","listIndex":3}},{"content":"4. Kiiski et al. (2020) - Functional EEG connectivity","children":[],"payload":{"tag":"li","lines":"92,93","listIndex":4}},{"content":"5. Kim et al. (2021) - Machine learning mismatch negativity","children":[],"payload":{"tag":"li","lines":"93,94","listIndex":5}},{"content":"6. Mueller et al. (2011) - ERP components discrimination","children":[],"payload":{"tag":"li","lines":"94,95","listIndex":6}},{"content":"7. M&#xfc;ller et al. (2020) - EEG/ERP biomarkers","children":[],"payload":{"tag":"li","lines":"95,96","listIndex":7}},{"content":"8. Poil et al. (2014) - Age-dependent EEG changes (<strong>children included?</strong>)","children":[],"payload":{"tag":"li","lines":"96,97","listIndex":8}},{"content":"9. Ponomarev et al. (2014) - Group ICA and current source density","children":[],"payload":{"tag":"li","lines":"97,98","listIndex":9}},{"content":"10. Shahaf et al. (2012) - Network oriented ERP analysis","children":[],"payload":{"tag":"li","lines":"98,101","listIndex":10}}],"payload":{"tag":"h2","lines":"86,87"}},{"content":"Performance Validity/Effort Testing/Symptom Exaggeration","children":[{"content":"Performance-based &apos;embedded&apos; validity indicators","children":[{"content":"1. Becke et al (2023) - Comprehensive Neuropsychological Test Battery + WURS","children":[],"payload":{"tag":"li","lines":"106,107","listIndex":1}},{"content":"2. Berger et al (2021) - MOXO-d-CPT","children":[],"payload":{"tag":"li","lines":"107,108","listIndex":2}},{"content":"3. Finley et al. (2023) - Embedded performance validity indicators","children":[],"payload":{"tag":"li","lines":"108,109","listIndex":3}},{"content":"4. Khan et al. (2022) - Stroop test embedded indicators","children":[],"payload":{"tag":"li","lines":"109,110","listIndex":4}},{"content":"5. Robinson et al. (2023) - CPT-3 validity indicators","children":[],"payload":{"tag":"li","lines":"110,111","listIndex":5}},{"content":"6. Harrison and Armstrong (2020) - TOVA","children":[],"payload":{"tag":"li","lines":"111,112","listIndex":6}},{"content":"7. Rogers et al. (2021) - WAIS-IV detection strategies","children":[],"payload":{"tag":"li","lines":"112,113","listIndex":7}},{"content":"8. Phillips et al. (2023) - RAVLT + BVMT-R","children":[],"payload":{"tag":"li","lines":"113,115","listIndex":8}}],"payload":{"tag":"h3","lines":"104,105"}},{"content":"Performance-based &apos;standalone&apos; validity indicators","children":[{"content":"1. Morey (2019) - Tests of Attentional Distraction (TOAD)","children":[],"payload":{"tag":"li","lines":"117,118","listIndex":1}},{"content":"2. Williamson et al. (2014) - TOMM, LMT, NV-MSVT, DMT","children":[],"payload":{"tag":"li","lines":"118,119","listIndex":2}},{"content":"3. Abramson et al (2023) - Dot Counting Test (DCT)","children":[],"payload":{"tag":"li","lines":"119,120","listIndex":3}},{"content":"4. Fuermaier et al (2016) - Embedded Figures Test","children":[],"payload":{"tag":"li","lines":"120,122","listIndex":4}}],"payload":{"tag":"h3","lines":"115,116"}},{"content":"Symptom exaggeration rating scales","children":[{"content":"1. Aita et al. (2018) - Personality Assessment Inventory feigning","children":[],"payload":{"tag":"li","lines":"124,125","listIndex":1}},{"content":"2. Cook et al. (2016) - Conners&apos; Infrequency Index validation","children":[],"payload":{"tag":"li","lines":"125,126","listIndex":2}},{"content":"3. Courr&#xe9;g&#xe9; et al. (2019) - ADHD Symptom Infrequency Scale","children":[],"payload":{"tag":"li","lines":"126,127","listIndex":3}},{"content":"4. Finley et al (2024) - Clinical Assessment of Attention Deficit&#x2013;Adult","children":[],"payload":{"tag":"li","lines":"127,128","listIndex":4}},{"content":"5. Harrison &amp; Armstrong (2016) - Exaggeration Index (EI)","children":[],"payload":{"tag":"li","lines":"128,129","listIndex":5}},{"content":"6. Harrison et al. (2022) - PAI validity measures","children":[],"payload":{"tag":"li","lines":"129,130","listIndex":6}},{"content":"7. Musso et al. (2016) - PAI utility","children":[],"payload":{"tag":"li","lines":"130,131","listIndex":7}},{"content":"8. Potts et al. (2022) - Multidimensional ADHD Rating Scale","children":[],"payload":{"tag":"li","lines":"131,132","listIndex":8}},{"content":"9. Ramachandran et al. (2019) - Subtle ADHD Malingering Screener","children":[],"payload":{"tag":"li","lines":"132,133","listIndex":9}},{"content":"10. Smith et al. (2017) - PAI feigning detection","children":[],"payload":{"tag":"li","lines":"133,134","listIndex":10}},{"content":"11. Young &amp; Gross (2011) - MMPI-2","children":[],"payload":{"tag":"li","lines":"134,137","listIndex":11}}],"payload":{"tag":"h3","lines":"122,123"}},{"content":"Combined neurocog test + rating scale","children":[{"content":"1. Sollman et al. (2010) - CAARS + TOMM, LMT, NVMST","children":[],"payload":{"tag":"li","lines":"139,140","listIndex":1}},{"content":"2. Quinn (2003) - ADHD Behav Checklist + IVA CPT","children":[],"payload":{"tag":"li","lines":"140,141","listIndex":2}},{"content":"3. Marshall et al. (2010) - WMT, CAT-A, b Test, DCT, etc","children":[],"payload":{"tag":"li","lines":"141,142","listIndex":3}},{"content":"4. Harrison et al (2007) - CAARS, Woodcock Johnson Psychoeducational Battery-III","children":[],"payload":{"tag":"li","lines":"142,144","listIndex":4}}],"payload":{"tag":"h3","lines":"137,138"}}],"payload":{"tag":"h2","lines":"101,102"}},{"content":"Biomarkers","children":[{"content":"1. Andrikopoulos et al. (2024) - Machine learning with physiological data","children":[],"payload":{"tag":"li","lines":"146,147","listIndex":1}},{"content":"2. Gr&#xfc;nblatt et al. (2012) - Transcription markers in whole blood","children":[],"payload":{"tag":"li","lines":"147,148","listIndex":2}},{"content":"3. Jiminez et al (2021) - Eye vergence/oculomotor","children":[],"payload":{"tag":"li","lines":"148,149","listIndex":3}},{"content":"4. Juselius Baghdassarian et al. (2018) - Auditory brainstem response (ABR)","children":[],"payload":{"tag":"li","lines":"149,150","listIndex":4}},{"content":"5. Selek et al. (2012) - Total Antioxidative Status (TAS), Total<br>\nOxidative Status (TOS), and Oxidative Stress Index (OSI)","children":[],"payload":{"tag":"li","lines":"150,152","listIndex":5}},{"content":"6. Udal et al. (2024) - Neuromuscular assessment","children":[],"payload":{"tag":"li","lines":"152,153","listIndex":6}},{"content":"7. Woodruff et al. (2011) - A new blood test that measures blood cell membrane<br>\npotential (expressed as membrane potential ratio [MPRTM])","children":[],"payload":{"tag":"li","lines":"153,156","listIndex":7}}],"payload":{"tag":"h2","lines":"144,145"}},{"content":"Unclassified/Problematic Studies","children":[{"content":"1. Groom et al (2016) - CAARS + Autism scale + QB Test","children":[],"payload":{"tag":"li","lines":"158,159","listIndex":1}},{"content":"2. Matte et al (2015) - Checking DSM-5 criteria for adults (e.g., lowering<br>\nthreshold)","children":[],"payload":{"tag":"li","lines":"159,161","listIndex":2}},{"content":"3. Gillen (2003) - Dissertation","children":[],"payload":{"tag":"li","lines":"161,162","listIndex":3}}],"payload":{"tag":"h2","lines":"156,157"}}],"payload":{"tag":"h1","lines":"0,1"}},{})</script>
</body>
</html>
